Evidence that the atypical 5‐HT<sub>3</sub> receptor ligand, [<sup>3</sup>H]‐BRL46470, labels additional 5‐HT<sub>3</sub> binding sites compared to [<sup>3</sup>H]‐granisetronLucinda J. Steward, Thomas P. Blackburn, Kim R Bentley et al.|British Journal of Pharmacology|1995Cited by 30
Integrated multi-target pharmacology of ginseng in acute myeloid leukemia through single-cell sequencing, molecular docking, network pharmacology, and in vitro experimentsYan Zhang, Jian Ge|Discover Oncology|2026Cited by 0